Clarivate has recently published the latest edition of Journal Citation ReportsTM providing information for the category ranking and Impact Factor ratings of indexed journals in 2020. Bentham Science journals have performed well and received good Impact Factor rankings this year. 35 out of our 40 ranked journals have secured a higher Impact Factor, while 5 journals have, more or less, maintained their ratings.
Current Neuropharmacology has proved to be the most impactful title from our catalog again over the last year in terms of publishing quality research that has been readily cited by the researchers worldwide. Its Impact Factor has increased to 7.363 from 4.668 In the previous period.
Other highlights in the report include Current Gene Therapy (Impact Factor 2020: 4.391) and Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2020: 4.169), which have received an appreciable increase in Impact Factors.
Bentham Science congratulates all of its contributors and looks forward to raising the bar on publishing impactful research for the benefit of the global scientific community.
Here is the list of all of Bentham’s Impact Factor journals.
BSP JOURNALS | 2019 | 2020 |
---|
CURRENT NEUROPHARMACOLOGY | 4.668 | 7.363 |
CURRENT MEDICINAL CHEMISTRY | 4.184 | 4.53 |
CURRENT GENE THERAPY | 2.431 | 4.391 |
CNS NEUROLOGICAL DISORDERS -DRUG TARGETS | 0 | 4.388 |
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY | 2.61 | 4.169 |
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2.733 | 3.862 |
CURRENT STEM CELL RESEARCH & THERAPY | 2.614 | 3.828 |
CURRENT DRUG METABOLISM | 2.96 | 3.731 |
CURRENT BIOINFORMATICS | 2.068 | 3.543 |
CURRENT ALZHEIMER RESEARCH | 3.047 | 3.498 |
CURRENT DRUG TARGETS | 2.632 | 3.465 |
CURRENT CANCER DRUG TARGETS | 2.912 | 3.428 |
CURRENT MOLECULAR PHARMACOLOGY | 3.283 | 3.339 |
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 3.218 | 3.295 |
CURRENT PROTEIN & PEPTIDE SCIENCE | 2.52 | 3.272 |
CURRENT PHARMEUTICAL DESIGN | 2.208 | 3.116 |
ENDOCRINE, METABOLIC & IMMUNE DISORDERS - DRUG TARGETS | 1.973 | 2.895 |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2.097 | 2.837 |
MEDICINAL CHEMISTRY | 2.577 | 2.745 |
CURRENT VASCULAR PHARMACOLOGY | 2.672 | 2.719 |
CURRENT DRUG DELIVERY | 1.582 | 2.565 |
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2.049 | 2.505 |
MINI-REVIEWS IN ORGANIC CHEMISTRY | 1.824 | 2.495 |
CURRENT GENOMICS | 2.63 | 2.236 |
CURRENT MOLECULAR MEDICINE | 1.6 | 2.222 |
CURRENT ORGANIC CHEMISTRY | 1.933 | 2.18 |
CURRENT NEUROVASCULAR RESEASRCH | 1.649 | 1.99 |
CURRENT ORGANIC SYNTHESIS | 1.983 | 1.975 |
RECENT PATENTS ON NANOTECHNOLOGY | 0.977 | 1.952 |
CURRENT ANALYTICAL CHEMISTRY | 1.365 | 1.892 |
PROTEIN & PEPTIDE LETTERS | 1.156 | 1.89 |
CURRENT NANOSCIENCE | 1.836 | 1.824 |
CURRENT COMPUTER-AIDED DRUG DESIGN | 0.935 | 1.606 |
CURRENT HIV RESEASRCH | 0.802 | 1.581 |
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 1.195 | 1.339 |
LETTERS IN DRUG DESIGN & DISCOVERY | 1.169 | 1.15 |
CURRENT PHARMACEUTICAL ANALYSIS | 0.923 | 0.89 |
LETTERS IN ORGANIC CHEMISTRY | 0.779 | 0.867 |
CURRENT MEDICAL IMAGING | 0.812 | 0.858 |
CURRENT PROTEOMICS | 0.68 | 0.837 |